← Open Payments lookup

PAYAL PATEL: Open Payments

NPI 1568927580 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$246 in 12 payments from 9 companies in 2025. Trend: 2023 $289 · 2024 $474 · 2025 $246

Food & beverage: $246
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.2$50
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Lundbeck LLC2$32
Neurocrine BioSciences, Inc.1$28
ABBVIE INC.1$23
Alkermes, Inc.1$22
Almatica Pharma LLC1$21
W. L. Gore & Associates, Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$14

Products named: ABILIFY ASIMTUFII, CAPLYTA, INGREZZA, REXULTI, VRAYLAR, LYBALVI, LOREEV XR, GORE VIABAHN VBX Balloon Expandable Endo.

Industry payments across TX — which companies pay providers there.